SG11202102345SA - Iron chelating compounds for treating aesthetic skin conditions - Google Patents
Iron chelating compounds for treating aesthetic skin conditionsInfo
- Publication number
- SG11202102345SA SG11202102345SA SG11202102345SA SG11202102345SA SG11202102345SA SG 11202102345S A SG11202102345S A SG 11202102345SA SG 11202102345S A SG11202102345S A SG 11202102345SA SG 11202102345S A SG11202102345S A SG 11202102345SA SG 11202102345S A SG11202102345S A SG 11202102345SA
- Authority
- SG
- Singapore
- Prior art keywords
- skin conditions
- chelating compounds
- iron chelating
- aesthetic skin
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0291—Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862734164P | 2018-09-20 | 2018-09-20 | |
| PCT/US2019/052192 WO2020061474A1 (en) | 2018-09-20 | 2019-09-20 | Iron chelating compounds for treating aesthetic skin conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202102345SA true SG11202102345SA (en) | 2021-04-29 |
Family
ID=69887931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202102345SA SG11202102345SA (en) | 2018-09-20 | 2019-09-20 | Iron chelating compounds for treating aesthetic skin conditions |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210315789A1 (en) |
| EP (1) | EP3852711A4 (en) |
| JP (1) | JP2022501372A (en) |
| KR (1) | KR20210065968A (en) |
| CN (1) | CN113038920A (en) |
| AU (1) | AU2019342136A1 (en) |
| BR (1) | BR112021004905A2 (en) |
| CA (1) | CA3113175A1 (en) |
| CL (1) | CL2021000660A1 (en) |
| IL (1) | IL281405A (en) |
| SG (1) | SG11202102345SA (en) |
| WO (1) | WO2020061474A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3917525B1 (en) | 2019-01-28 | 2024-02-28 | Tomorrowlabs GmbH | New topical formulation for use in alopecia |
| WO2023034701A1 (en) * | 2021-08-30 | 2023-03-09 | Tautona Group Ip Holding Company, L.L.C. | Hif-1 promoting compounds for treating autonomic skin dysfunction following spinal cord injury |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR7302M (en) * | 1966-03-04 | 1969-09-29 | ||
| ATE176396T1 (en) * | 1987-10-22 | 1999-02-15 | Procter & Gamble | LIGHT PROTECTIVE AGENTS CONTAINING CHELATES |
| JPH10182407A (en) * | 1996-12-24 | 1998-07-07 | Kose Corp | Preparation for external use for skin |
| JP2000136122A (en) * | 1998-10-28 | 2000-05-16 | Kose Corp | Skin lotion |
| FR2825920B1 (en) * | 2001-06-15 | 2006-04-28 | Oreal | DESFERAL AS INHIBITOR OF NO-SYNTHASE AND USES |
| CA2505476C (en) * | 2002-11-07 | 2015-05-26 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| ITMI20022447A1 (en) * | 2002-11-19 | 2004-05-20 | Carlo Ghisalberti | USE OF PYRIDINONS IN THE TREATMENT OF CAPILLARY PURPURE AND RELATED SKIN DISEASES. |
| EP1686957B1 (en) * | 2003-11-17 | 2012-03-07 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
| FR2869229B1 (en) * | 2004-04-26 | 2006-08-25 | Sederma Soc Par Actions Simpli | USE OF A INDUCER OF UGT BY TOPIC |
| US8829051B2 (en) * | 2004-05-24 | 2014-09-09 | Geoffrey C. GURTNER | Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux |
| US7763289B2 (en) * | 2005-09-01 | 2010-07-27 | JoAl's Products, LLC | Topical turmeric skin care products |
| ITMI20052262A1 (en) * | 2005-11-25 | 2007-05-26 | Fitologica Srl | PHARMACEUTICAL COMPOSITIONS E-O TOPIC DERMATOCOSMETICS FOR THE TREATMENT OF ANDROGENETIC ALOPECIA |
| FR2900573B1 (en) * | 2006-05-05 | 2014-05-16 | Sederma Sa | NOVEL COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE PEPTIDE CONTAINING AT LEAST ONE BLOCKED AROMATIC CYCLE |
| US20140370078A1 (en) * | 2013-06-12 | 2014-12-18 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds |
| US20100092546A1 (en) * | 2008-10-10 | 2010-04-15 | Gurtner Geoffrey C | Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds |
| US10098857B2 (en) * | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
| WO2011056667A2 (en) * | 2009-10-28 | 2011-05-12 | Guthery Eugene B | Rosacea topical skin treatment method and formulation |
| US20100172865A1 (en) * | 2010-03-18 | 2010-07-08 | Shantha Totada R | Methods of enhancing hair growth |
| GB2481712B (en) * | 2010-06-30 | 2013-01-30 | Pangaea Lab Ltd | Composition comprising vascular endothelial growth factor (VEGF) for the treatment of hair loss |
| IN2014DN11158A (en) * | 2012-07-12 | 2015-10-02 | Dsm Ip Assets Bv | |
| EA037605B1 (en) * | 2014-02-18 | 2021-04-20 | Медзис Фарма | Use of reverse-micellar systems for delivering chelators of radionuclides and metals |
| US20160199437A1 (en) * | 2015-01-08 | 2016-07-14 | D. Travis Wilson | Therapeutic compositions including iron chelators and uses thereof |
| CA2989145A1 (en) * | 2015-06-17 | 2016-12-22 | Dispersol Technologies, Llc | Improved formulations of deferasirox and methods of making the same |
-
2019
- 2019-09-20 CN CN201980074073.6A patent/CN113038920A/en active Pending
- 2019-09-20 AU AU2019342136A patent/AU2019342136A1/en not_active Abandoned
- 2019-09-20 JP JP2021515532A patent/JP2022501372A/en active Pending
- 2019-09-20 EP EP19862327.4A patent/EP3852711A4/en not_active Withdrawn
- 2019-09-20 SG SG11202102345SA patent/SG11202102345SA/en unknown
- 2019-09-20 CA CA3113175A patent/CA3113175A1/en active Pending
- 2019-09-20 WO PCT/US2019/052192 patent/WO2020061474A1/en active Application Filing
- 2019-09-20 US US17/273,855 patent/US20210315789A1/en not_active Abandoned
- 2019-09-20 KR KR1020217011391A patent/KR20210065968A/en active Search and Examination
- 2019-09-20 BR BR112021004905-3A patent/BR112021004905A2/en not_active Application Discontinuation
-
2021
- 2021-03-10 IL IL281405A patent/IL281405A/en unknown
- 2021-03-17 CL CL2021000660A patent/CL2021000660A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210065968A (en) | 2021-06-04 |
| CL2021000660A1 (en) | 2021-10-01 |
| BR112021004905A2 (en) | 2021-06-01 |
| JP2022501372A (en) | 2022-01-06 |
| CN113038920A (en) | 2021-06-25 |
| US20210315789A1 (en) | 2021-10-14 |
| EP3852711A1 (en) | 2021-07-28 |
| IL281405A (en) | 2021-04-29 |
| EP3852711A4 (en) | 2022-06-08 |
| CA3113175A1 (en) | 2020-03-26 |
| WO2020061474A1 (en) | 2020-03-26 |
| AU2019342136A1 (en) | 2021-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3728271T1 (en) | Macrocyclic compounds for treating diseases | |
| IL257587B (en) | Compounds for treating amyotrophic lateral sclerosis | |
| ZA202001283B (en) | Iron complex compounds for therapeutic use | |
| IL271018A (en) | Compounds for treating tnbc | |
| IL287907A (en) | Methods for treating cancer | |
| SG11202010528XA (en) | Combinations for treating cancer | |
| IL281427A (en) | Compounds for treating certain leukemias | |
| EP3966208A4 (en) | Compounds and methods for treating cancer | |
| IL281405A (en) | Iron chelators for treating aesthetic skin conditions | |
| IL261774B (en) | Compositions for treating dermatological conditions | |
| IL282703A (en) | Novel compounds useful for treating cardiovascular diseases | |
| GB201909468D0 (en) | Compounds for treating cancer | |
| GB201809890D0 (en) | Chronotherapeutic treatment profiling | |
| IL289201A (en) | Compounds for treatment of cancer | |
| ZA202006810B (en) | Process for treating hair | |
| PL3630754T3 (en) | Isoindoline-acetylene compounds for the treatment of cancer | |
| EP3445384C0 (en) | Composition for treating diastolic dysfunction | |
| GB201909466D0 (en) | Compounds for treating cancer | |
| IL290319A (en) | Compound for combination treatment | |
| IL292136A (en) | Vector for cancer treatment | |
| IL284668A (en) | Methods for treating schizophrenia | |
| EP4058063A4 (en) | Methods for treating diseases | |
| GB202007652D0 (en) | Compounds for treating covid-19 | |
| EP4019634A4 (en) | Compounds and methods for treating cancer | |
| IL278984A (en) | Safinamide for treating myotonia |